Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Poteligeo injection launched in Japan for adult T-cell leukemia-lymphoma

May 29, 2012

Merck & Co. patents new hPDK1 inhibitors

May 29, 2012

PharmaGap conditionally approves offer for GAP-107B8 license

May 25, 2012

Chugai files for approval in Japan of pertuzumab

May 25, 2012

Oryzon set to begin preclinical development of hematological cancer drug

May 25, 2012

Kancera's ROR inhibitors show activity against fludarabine-resistant CLL

May 25, 2012

Anti-IL10 receptor monoclonal antibody enhances BCG antitumor responses

May 25, 2012

Bionomics commences phase I/II trial of vasculature-disrupting agent in ovarian cancer

May 25, 2012

Pfizer describes novel antiandrogen for castration-resistant prostate cancer

May 25, 2012

Research in Korea yields new HIF1-alpha inhibitors

May 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...